HANNAH SCHNEPP: Open Payments
NPI 1841854874 · OXFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$868 in 54 payments from 9 companies in 2025. Trend: 2023 $299 · 2024 $770 · 2025 $868
Food & beverage: $868
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 32 | $404 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $130 |
| Astellas Pharma US Inc | 3 | $88 |
| Sage Therapeutics, LLC | 3 | $74 |
| Sumitomo Pharma America, Inc. | 2 | $45 |
| CooperSurgical, Inc. | 2 | $43 |
| Aspira Women's Health Inc | 1 | $33 |
| Exact Sciences Corporation | 1 | $31 |
| MILLICENT US INC | 1 | $20 |
Products named: SLYND, NUVESSA, Veozah, ZURZUVAE, TYBLUME, MYFEMBREE, Paragard T 380A, OVA1.
Industry payments across CT — which companies pay providers there.
